Sareum (SAR) Competitors GBX 26.55 -0.45 (-1.67%) (As of 11:23 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider Trades SAR vs. SPE, GRX, CHI, PHD, FEN, NMT, GLV, CGO, TSI, and MYNShould you be buying Sareum stock or one of its competitors? The main competitors of Sareum include Sopheon (SPE), GreenX Metals (GRX), CT UK High Income Trust (CHI), Proactis (PHD), Frenkel Topping Group (FEN), Neometals (NMT), Glenveagh Properties (GLV), Contango (CGO), Two Shields Investments Plc (TSI.L) (TSI), and Mayan Energy (MYN). These companies are all part of the "financial services" industry. Sareum vs. Sopheon GreenX Metals CT UK High Income Trust Proactis Frenkel Topping Group Neometals Glenveagh Properties Contango Two Shields Investments Plc (TSI.L) Mayan Energy Sareum (LON:SAR) and Sopheon (LON:SPE) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, community ranking, institutional ownership, risk, profitability, media sentiment, valuation, analyst recommendations and earnings. Is SAR or SPE more profitable? Sareum has a net margin of 0.00% compared to Sopheon's net margin of -0.14%. Sopheon's return on equity of -0.18% beat Sareum's return on equity.Company Net Margins Return on Equity Return on Assets SareumN/A -257.72% -113.80% Sopheon -0.14%-0.18%2.70% Does the MarketBeat Community believe in SAR or SPE? Sopheon received 81 more outperform votes than Sareum when rated by MarketBeat users. However, 66.13% of users gave Sareum an outperform vote while only 59.49% of users gave Sopheon an outperform vote. CompanyUnderperformOutperformSareumOutperform Votes8266.13% Underperform Votes4233.87% SopheonOutperform Votes16359.49% Underperform Votes11140.51% Which has stronger valuation & earnings, SAR or SPE? Sopheon has higher revenue and earnings than Sareum. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSareum£47.20K607.17-£4.25M-£0.06-442.50Sopheon£38.12M0.00N/AN/AN/A Do insiders & institutionals believe in SAR or SPE? 41.4% of Sopheon shares are held by institutional investors. 5.0% of Sareum shares are held by company insiders. Comparatively, 48.9% of Sopheon shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has more volatility and risk, SAR or SPE? Sareum has a beta of -1.08, suggesting that its stock price is 208% less volatile than the S&P 500. Comparatively, Sopheon has a beta of 0.44, suggesting that its stock price is 56% less volatile than the S&P 500. Does the media favor SAR or SPE? In the previous week, Sareum's average media sentiment score of 0.00 equaled Sopheon'saverage media sentiment score. Company Overall Sentiment Sareum Neutral Sopheon Neutral SummarySopheon beats Sareum on 7 of the 10 factors compared between the two stocks. Ad DarwinMarket Winners Post-Election: Your Exclusive Report InsideThe dust has settled on the 2024 elections, and markets are already responding to the new political landscape. Now is the perfect time to adjust your strategy and take advantage of fresh opportunities emerging from these developments. We’re excited to share our updated report, “Post-Election Investment Gems: Top Stocks Set to Thrive in 2025.” This guide is designed to equip you with timely insights and actionable strategies in today’s evolving market.[Download your free report now] to stay ahead of the curve and uncover market opportunities you can’ Get Sareum News Delivered to You Automatically Sign up to receive the latest news and ratings for SAR and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SAR vs. The Competition Export to ExcelMetricSareumBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£28.66M£178.49M£5.16B£1.94BDividend Yield1.10%3.64%4.96%5.20%P/E Ratio-442.50115.3586.541,915.29Price / Sales607.1719,285.741,126.05480,436.82Price / Cash11.3213.0143.2729.12Price / Book26.559.394.823.01Net Income-£4.25M-£20.89M£120.07M£183.02M7 Day Performance-2.93%0.51%1.23%21.47%1 Month Performance-3.45%231.81%16.54%27.05%1 Year Performance-55.38%151.37%28.85%153.17% Sareum Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SARSareumN/AGBX 26.55-1.7%N/A-54.6%£28.66M£47,204.00-442.503,211SPESopheonN/AN/AN/AN/A£106.03M£38.12M-9,500.00174GRXGreenX MetalsN/AGBX 33-2.9%N/A-34.0%£92.24M£261,543.00-3,300.00N/AGap DownCHICT UK High Income TrustN/AGBX 95.90+0.9%N/A+16.3%£79.90M£13.28M959.00N/AGap UpPHDProactisN/AN/AN/AN/A£70.69M£48.90M-3.57516FENFrenkel Topping GroupN/AGBX 42.50-1.2%N/A-30.3%£52.22M£32.81M4,250.00307Gap DownHigh Trading VolumeNMTNeometalsN/AGBX 2.99-0.1%N/A-73.4%£20.62MN/A-99.63N/ANews CoverageGap DownGLVGlenveagh PropertiesN/AGBX 1.60-3.3%N/A+35.7%£9.23M£588.54M19.95502Gap DownCGOContangoN/AGBX 1.22-0.3%N/A-53.2%£6.91MN/A-122.002,219TSITwo Shields Investments Plc (TSI.L)N/AN/AN/AN/A£6.15MN/A-1.053MYNMayan EnergyN/AN/AN/AN/A£5.28M£-3,000.00-0.235Gap Up Related Companies and Tools Related Companies Sopheon Competitors GreenX Metals Competitors CT UK High Income Trust Competitors Proactis Competitors Frenkel Topping Group Competitors Neometals Competitors Glenveagh Properties Competitors Contango Competitors Two Shields Investments Plc (TSI.L) Competitors Mayan Energy Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:SAR) was last updated on 12/30/2024 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored3 CENT Crypto to Explode December 16th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredI was wrong. Dead wrong. Something is stirring deep in Silicon Valley. My team and I have been watching the tech markets closely. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sareum Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Sareum With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
